All Stories

  1. Message or messenger, that's the right question
  2. Super-infection by multiple microorganisms in COVID-19 patients
  3. Class 1 and 2 Integrons in Escherichia coli Strains Isolated from Diarrhea and Bacteremia in Children Less Than 2 Years of Age from Peru
  4. First report of CrpP prevalence in a South American country
  5. Phenotypic Characteristics and Clonal Relationships of Stenotrophomonas maltophilia Isolates in Hospitalized Adults from a Private Center in Lima, Peru
  6. JMM Profile: Bartonella bacilliformis: a forgotten killer
  7. High rates of extensively drug-resistant Acinetobacter baumannii in a Peruvian hospital 2013–2019
  8. KPC-2-NDM-1-producing Serratia marcescens: first description in Peru
  9. Evolution of the prevalence and antimicrobial resistance among Escherichia coli isolated as a cause of infection in patients admitted to a iv-level hospital in Lima, Peru
  10. Antibiotic susceptibility among non-clinical Escherichia coli as a marker of antibiotic pressure in Peru (2009–2019): one health approach
  11. Recurrence of Urinary Tract Infections due to Escherichia coli and Its Association with Antimicrobial Resistance
  12. COVID-19: chronicle of a pandemic foretold
  13. Worrying levels of antimicrobial resistance in Gram-negative bacteria isolated from cell phones and uniforms of Peruvian intensive care unit workers
  14. High Prevalence of blaCTX-M in Fecal Commensal Escherichia coli from Healthy Children
  15. Retrospective analysis of the emergence of antibiotic-resistant Salmonella enterica infections in a level IV hospital from Lima, Peru
  16. Antimicrobial Resistance, from bench-to-publicside
  17. Immunogenic Peptides from Pap31 and SCS-α of Bartonella bacilliformis: One Step Closer to a Rapid Diagnostic Tool for Carrion’s Disease
  18. Molecular Characterization of Fluoroquinolone-Resistant Bartonella bacilliformis
  19. Type 3 secretion system as an anti-Pseudomonal target
  20. Type 3 secretion system of Pseudomonas aeruginosa
  21. Caracterización de Escherichia coli D7111 productora de β-lactamasa TEM-176
  22. Frecuencia de genes que codifican proteínas autotransportadoras serinproteasa de Enterobacteriaceae (SPATE) en cepas de Escherichia coli difusamente adherente (DAEC) provenientes de niños con y sin diarrea
  23. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital
  24. Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?
  25. Research inequities: avoiding the next pandemic
  26. Escherichia coli ST131 clones harbouring AggR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of fimH27 subclone
  27. Resistencia a nitrofuranos mediada por mutaciones en los genes cnr y snrA en Salmonella enterica procedentes de muestras cárnicas para consumo humano
  28. Transferable Mechanisms of Quinolone Resistance from 1998 Onward
  29. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
  30. CrpP, a passenger or a hidden stowaway in the Pseudomonas aeruginosa genome?
  31. Presence of Extended-Spectrum β-lactamase, CTX-M-65 in Salmonella enterica serovar Infantis Isolated from Children with Diarrhea in Lima, Peru
  32. Azithromycin resistance levels and mechanisms in Escherichia coli
  33. Reflexión acerca del concepto de “Una salud”
  34. Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa
  35. Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
  36. Bartonella quintana , past, present, and future of the scourge of World War I
  37. Revisiting Bartonella bacilliformis MLST
  38. Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, M...
  39. Differences in tetracycline resistance determinant carriage among Shigella flexneri and Shigella sonnei are not related to different plasmid Inc-type carriage
  40. Analysis of the presence of erroneous Qnr sequences in GenBank
  41. Salmonella enterica serovars Typhimurium and Enteritidis causing mixed infections in febrile children in Mozambique
  42. Resistance to quinolones, cephalosporins and macrolides in Escherichia coli causing bacteraemia in Peruvian children
  43. Carrion's Disease: the Sound of Silence
  44. Molecular and Phenotypic Characterization of Diarrheagenic Escherichia coli Strains Isolated from Bacteremic Children
  45. Immunosuppressive and angiogenic cytokine profile associated with Bartonella bacilliformis infection in post-outbreak and endemic areas of Carrion's disease in Peru
  46. Characterisation of the first KPC-2-producing Klebsiella pneumoniae ST340 from Peru
  47. Virulence and Antimicrobial Resistance inCampylobacterspp. from a Peruvian Pediatric Cohort
  48. Antimicrobial resistance levels among diarrhoeagenic micro-organisms recovered from children under-5 with acute moderate-to-severe diarrhoea in Rabat, Morocco
  49. Carrion’s disease: an eradicable illness?
  50. Macrolide resistance mechanisms inEnterobacteriaceae: Focus on azithromycin
  51. Carrion’s Disease: More Than a Sand Fly–Vectored Illness
  52. Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants
  53. Succinyl-CoA Synthetase: New Antigen Candidate of Bartonella bacilliformis
  54. Virulence factors profiles and ESBL production in Escherichia coli causing bacteremia in Peruvian children
  55. Whole-Genome Sequencing of Two Bartonella bacilliformis Strains
  56. picgene of enteroaggregativeEscherichia coliand its association with diarrhea in Peruvian children
  57. Pathogenicity Island O-122 in enteropathogenic Escherichia coli strains is associated with diarrhea severity in children from Lima Peru
  58. Prevalencia de compra sin receta y recomendación de antibióticos para niños menores de 5 años en farmacias privadas de zonas periurbanas en Lima, Perú
  59. Evaluation of PCR Approaches for Detection of Bartonella bacilliformis in Blood Samples
  60. Multi-Locus Sequence Typing of Bartonella bacilliformis DNA Performed Directly from Blood of Patients with Oroya’s Fever During a Peruvian Outbreak
  61. Bordetella pertussis diagnosis in children under five years of age in the Regional Hospital of Cajamarca, Northern Peru
  62. InvasiveSalmonellaInfections Among Children From Rural Mozambique, 2001–2014
  63. Antibiotic resistance in Bartonella bacilliformis clinical isolates from an endemic area of Peru
  64. Proteins of Bartonella bacilliformis: Candidates for Vaccine Development
  65. Comparative analysis of antimicrobial resistance in enterotoxigenicEscherichia coliisolates from two paediatric cohort studies in Lima, Peru
  66. A comparison of human metapneumovirus and respiratory syncytial virus WHO-defined severe pneumonia in Moroccan children
  67. Characterization of two Achromobacter xylosoxidans isolates from patients with pertussis-like symptoms
  68. Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru)
  69. Development and analysis of furazolidone‐resistant Escherichia coli mutants
  70. An unidentified cluster of infection in the Peruvian Amazon region
  71. Diarrheal Disease in Rural Mozambique: Burden, Risk Factors and Etiology of Diarrheal Disease among Children Aged 0–59 Months Seeking Care at Health Facilities
  72. Characterisation of extended-spectrum β-lactamases among Klebsiella pneumoniae isolates causing bacteraemia and urinary tract infection in Mozambique
  73. Possible Vertical Transmission of Bartonella bacilliformis in Peru
  74. Aetiology, epidemiology and clinical characteristics of acute moderate-to-severe diarrhoea in children under 5 years of age hospitalized in a referral paediatric hospital in Rabat, Morocco
  75. DiarrheagenicEscherichia coliPhylogroups Are Associated with Antibiotic Resistance and Duration of Diarrheal Episode
  76. Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco
  77. Feeding of Young Children During Diarrhea: Caregivers' Intended Practices and Perceptions
  78. Identification of human papillomavirus as a preventive strategy for cervical cancer in asymptomatic women in the Peruvian Andes
  79. Diarrhoea caused by rotavirus in a regional Peruvian hospital: determination of circulating genotypes
  80. Diagnosis of Carrion’s Disease by Direct Blood PCR in Thin Blood Smear Negative Samples
  81. The Epidemiology and Aetiology of Infections in Children Admitted with Clinical Severe Pneumonia to a University Hospital in Rabat, Morocco
  82. Development of a 16S rRNA PCR-RFLP Assay for Bartonella identification: Applicability in the Identification of Species Involved in Human Infections
  83. Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru
  84. Prevention of travellers' diarrhoea: where and who?
  85. Detection of Secretory Immunoglobulin A in Human Colostrum as Mucosal Immune Response Against Proteins of the Type III Secretion System of Salmonella, Shigella and Enteropathogenic Escherichia Coli
  86. Which mechanisms of azithromycin resistance are selected when efflux pumps are inhibited?
  87. Antibiotic Usage Prior and During Hospitalization for Clinical Severe Pneumonia in Children under Five Years of Age in Rabat, Morocco
  88. Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995–2010): A retrospective analysis
  89. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates
  90. Multiplex Real-Time PCR for Detection of Campylobacter, Salmonella, and Shigella
  91. Factors Affecting Caregivers’ Use of Antibiotics Available Without a Prescription in Peru
  92. In Vitro Development and Analysis of Escherichia coli and Shigella boydii Azithromycin–Resistant Mutants
  93. QnrVC, a new transferable Qnr-like family
  94. β-Lactamases, transferable quinolone resistance determinants, and class 1 integron-mediated antimicrobial resistance in human clinical Salmonella enterica isolates of non-Typhimurium serotypes
  95. Genotypic Characterization of Enterotoxigenic Escherichia coli Strains Causing Traveler's Diarrhea
  96. Molecular mechanisms of antibiotic resistance in diarrhoeagenic Escherichia coli isolated from children
  97. Transferable mechanisms of quinolone resistance
  98. Fitness and Molecular Mechanisms of Resistance to Rifaximin in In Vitro Selected Escherichia coli Mutants
  99. Genetic diversity of locus of enterocyte effacement genes of enteropathogenic Escherichia coli isolated from Peruvian children
  100. Intrahospitalary dissemination of Klebsiella pneumoniae carrying blaDHA-1 and qnrB4 genes within a novel complex class 1 integron
  101. Plasmid-mediated quinolone resistance genes in enteroaggregative Escherichia coli from infants in Lima, Peru
  102. Effect of bovine lactoferrin on the minimum inhibitory concentrations of ampicillin and trimethoprim–sulfamethoxazole for clinical Shigella spp. strains1This article is part of a Special Issue entitled Lactoferrin and has undergone th...
  103. Use of Commercially Available Oral Rehydration Solutions in Lima, Peru
  104. Niveles de resistencia a quinolonas y otros antimicrobianos en cepas de Escherichia coli comensales en niños de la zona periurbana de Lima, Perú
  105. Short communication: Detection of Shiga toxin-producing Escherichia coli (STEC) in healthy cattle and pigs in Lima, Peru
  106. Norovirus prevalence in ‘pathogen negative’ gastroenteritis in children from periurban areas in Lima, Peru
  107. Quantitative Real-time Polymerase Chain Reaction for Enteropathogenic Escherichia coli: A Tool for Investigation of Asymptomatic Versus Symptomatic Infections
  108. Molecular Surveillance of Circulating Dengue Genotypes Through European Travelers
  109. Molecular epidemiology and resistance mechanisms involved in reduced susceptibility to amoxicillin/clavulanic acid in Klebsiella pneumoniae isolates from a chronic care centre
  110. Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children
  111. Frecuencia y patotipos de Escherichia coli diarrogénicas en niños peruanos con y sin diarrea
  112. Antimicrobial Drug Resistance Trends of Bacteremia Isolates in a Rural Hospital in Southern Mozambique
  113. Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones
  114. Genetic analysis by pulsed-field gel electrophoresis of Enteropathogenic Escherichia coli (EPEC) strains isolated from Peruvian children
  115. Role of Efflux pumps in the development of quinolone-resistance in Peruvian Escherichia coli isolates
  116. Characterization of the enzyme aac(3)-id in a clinical isolate of Salmonella enterica serovar Haifa causing traveler's diarrhea
  117. Multidrug resistance related to class 1 integrons in human Salmonella enterica serotype Typhimurium isolates and emergence of atypical sul3-associated integrons
  118. Invasive non-typhoidal Salmonella in Mozambican children
  119. Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers
  120. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea
  121. Antimicrobial Susceptibility and Mechanisms of Resistance in Shigella and Salmonella Isolates from Children under Five Years of Age with Diarrhea in Rural Mozambique
  122. Estudio clinicoepidemiológico del dengue importado en España
  123. Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability
  124. Quinolone resistance among Shigella spp. isolated from travellers returning from India
  125. In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea
  126. Molecular typing of Staphylococcus aureus clinical isolates by pulsed-field gel electrophoresis, staphylococcal cassette chromosome mec type determination and dissemination of antibiotic resistance genes
  127. Epidemiology and Clinical Presentation of Shigellosis in Children Less Than Five Years of Age in Rural Mozambique
  128. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique
  129. Salmonella ovarian abscess following travel diarrhoea episode
  130. Resistance to quinolones in Salmonella infantis due to overexpression of an active efflux system and a mutation in the gyrA gene
  131. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea
  132. Molecular Epidemiology of Macrolide and Tetracycline Resistances in Commensal Gemella sp. Isolates
  133. Class 1 Integrons in Salmonella Strains Causing Traveler's Diarrhea
  134. Outbreak of Infection WithAcinetobacterStrain RUH 1139 in an Intensive Care Unit
  135. Evidence for a reserpine‐affected mechanism of resistance to tetracycline in Neisseria gonorrhoeae
  136. Ciprofloxacin, Salicylate, and 2,4-Dinitrophenol Decrease Production of AmpC-Type β-Lactamase in Two Citrobacter freundii Clinical Isolates
  137. Validación de la técnica de PCR para la detección de Escherichia coli enteroagregativa causante de diarrea del viajero
  138. A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates
  139. Prevalence of Pathogenicity Island IICFT073 Genes among Extraintestinal Clinical Isolates of Escherichia coli
  140. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa
  141. Mechanism of Resistance to Several Antimicrobial Agents in Salmonella Clinical Isolates Causing Traveler's Diarrhea
  142. Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins
  143. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates
  144. Mecanismos de resistencia a betalactámicos y ácido nalidíxico en aislados clínicos de Salmonella enterica serotipo hadar y bsilla
  145. Antibiotic resistance and epidemiological typing of Staphylococcus aureus strains from ovine and rabbit mastitis
  146. Molecular characterization of the integrons in S higella strains isolated from patients with traveler's diarrhea
  147. Effect of the efflux pump inhibitor Phe-Arg- -naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin
  148. Mecanismos de resistencia a betalactámicos y ácido nalidíxico en aislados clínicos de Salmonella enterica serotipo hadar y bsilla
  149. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance
  150. Blood Cultures for Women with Uncomplicated Acute Pyelonephritis: Are They Necessary?
  151. Dispersión intercontinental de una cepa de Shigella flexneri resistente a trimetoprima
  152. Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain
  153. Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii
  154. Detection of dihydrofolate reductase genes by PCR and RFLP
  155. Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
  156. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene
  157. Analysis of the clonal relationship among clinical isolates of Salmonella enterica serovar Infantis by different typing methods
  158. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
  159. Clonal Dissemination of Yersinia enterocolitica Strains with Various Susceptibilities to Nalidixic Acid
  160. Dispersión intercontinental de una cepa de Shigella flexneri resistente a trimetoprima
  161. Differences in Virulence Factors among Clinical Isolates of Escherichia coli Causing Cystitis and Pyelonephritis in Women and Prostatitis in Men
  162. Characterization of an Integron Carrying a New Class D β -Lactamase (OXA-37) in Acinetobacter baumannii
  163. Mutations in gyrA and parC QRDRs Are Not Relevant for Quinolone Resistance in Epidemiological Unrelated Stenotrophomonas maltophilia Clinical Isolates
  164. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus
  165. Are Quinolone‐Resistant UropathogenicEscherichia coliLess Virulent?
  166. Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics
  167. Prevalence of the sat Gene among Clinical Isolates of Shigella spp. Causing Travelers' Diarrhea: Geographical and Specific Differences
  168. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae
  169. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates
  170. Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates
  171. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine
  172. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis
  173. Decreased Invasive Capacity of Quinolone‐Resistant Escherichia coli in Patients with Urinary Tract Infections
  174. Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: emergence of quinolone resistance
  175. Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones
  176. Characterization of sparfloxacin-resistant mutants of Staphylococcus aureus obtained in vitro
  177. In vitro activity of rifaximin against bacterial enteropathogens causing diarrhoea in children under 5 years of age in Ifakara, Tanzania
  178. In Vitro Activity of Rifaximin against Enteropathogens Producing Traveler's Diarrhea
  179. Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus
  180. Quinolone Resistance in EnterotoxigenicEscherichia coli Causing Diarrhea in Travelers to India in Comparison with Other Geographical Areas
  181. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition
  182. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii
  183. Resolution of high-molecular-weight components in lipopolysaccharides of Escherichia coli, Morganella morganii, Citrobacter freundii and Citrobacter diversus strains with sodium dodecyl sulfate polyacrylamide gels
  184. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii
  185. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
  186. Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish
  187. Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance
  188. Decreased Production of AmpC-Type β-Lactamases Associated with the Development of Resistance to Quinolones inCitrobacter freundiiStrains
  189. Campylobacter jejuni as a Cause of Traveler's Diarrhea: Clinical Features and Antimicrobial Susceptibility
  190. Increased Resistance to Quinolones in Campylobacter jejuni: A Genetic Analysis of gyrA Gene Mutations in Quinolone‐Resistant Clinical Isolates
  191. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium
  192. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
  193. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates
  194. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii
  195. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coti
  196. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.